Jeff Yass’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Jeff Yass’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200,557	Closed	-$241	–	13433
2024 Q2	$241	Buy	200,557 +183,763	+1,094%	+$6.34K	﹤0.01%	11898
2024 Q1	$2.35K	Buy	+16,794	New	+$2.15K	﹤0.01%	11981
2021 Q3	–	Sell	-14,945	Closed	-$15K	–	13773
2021 Q2	$15K	Buy	+14,945	New	+$12.1K	﹤0.01%	12432

Jeff Yass's EFTRW Position: Q3 2024 in Review

Jeff Yass sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 200,557 shares — an estimated $241 sold.

Jeff Yass first reported a position in EFTRW in Q2 2021 and held it in 3 quarters. The position peaked at $15K in Q2 2021. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

Jeff Yass reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Jeff Yass sold 200,557 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $241.
Jeff Yass first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q2 2021 and held it in 3 quarters.
Jeff Yass's eFFECTOR Therapeutics, Inc. Warrant position peaked at $15K in Q2 2021.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.